TreeWAS – Variant ID: rs903107

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D22.3 Melanocytic naevi of other and unspecified parts of face	0.000	0.964	0.036
E04.2 Non-toxic multinodular goitre	0.000	0.983	0.017
L03.9 Cellulitis, unspecified	0.011	0.989	0.000
R41.3 Other amnesia	0.011	0.989	0.000
H40.0 Glaucoma suspect	0.000	0.990	0.010
B25.9 Cytomegaloviral disease, unspecified	0.010	0.990	0.000
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.990	0.010
H40 Glaucoma	0.000	0.991	0.009
B18.2 Chronic viral hepatitis C	0.000	0.991	0.009
H40.2 Primary angle-closure glaucoma	0.000	0.992	0.008
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.000	0.992	0.008
H40.5 Glaucoma secondary to other eye disorders	0.000	0.992	0.008
M89.0 Algoneurodystrophy	0.000	0.993	0.007
M89.06 Algoneurodystrophy (Lower leg)	0.000	0.993	0.007
H40.8 Other glaucoma	0.000	0.993	0.007
H40.3 Glaucoma secondary to eye trauma	0.000	0.993	0.007
E04 Other non-toxic goitre	0.000	0.993	0.007
B18 Chronic viral hepatitis	0.000	0.993	0.007
M89.07 Algoneurodystrophy (Ankle and foot)	0.000	0.993	0.007
H40.6 Glaucoma secondary to drugs	0.000	0.993	0.007
M89.09 Algoneurodystrophy (Site unspecified)	0.000	0.993	0.007
N82.3 Fistula of vagina to large intestine	0.000	0.993	0.007
G93.8 Other specified disorders of brain	0.000	0.994	0.006
H40.4 Glaucoma secondary to eye inflammation	0.000	0.994	0.006
H40.1 Primary open-angle glaucoma	0.000	0.994	0.006
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.994	0.006
M89.04 Algoneurodystrophy (Hand)	0.000	0.994	0.006
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.994	0.006
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.000	0.994	0.006
M89.00 Algoneurodystrophy (Multiple sites)	0.000	0.994	0.006
H40.9 Glaucoma, unspecified	0.000	0.994	0.006
B25 Cytomegaloviral disease	0.006	0.994	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.994	0.006
G93 Other disorders of brain	0.000	0.994	0.006
G93.5 Compression of brain	0.000	0.994	0.006
M89.03 Algoneurodystrophy (Forearm)	0.000	0.994	0.005
G91 Hydrocephalus	0.000	0.994	0.006
M89.08 Algoneurodystrophy (Other)	0.000	0.994	0.005
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.000	0.994	0.005
M89.02 Algoneurodystrophy (Upper arm)	0.000	0.994	0.005
M89.01 Algoneurodystrophy (Shoulder region)	0.000	0.994	0.005
E04.0 Non-toxic diffuse goitre	0.000	0.994	0.005
G91.1 Obstructive hydrocephalus	0.000	0.995	0.005
G91.8 Other hydrocephalus	0.000	0.995	0.005
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.005	0.995	0.000
E04.8 Other specified non-toxic goitre	0.000	0.995	0.005
B18.8 Other chronic viral hepatitis	0.000	0.995	0.005
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.995	0.005
G91.9 Hydrocephalus, unspecified	0.000	0.995	0.005
G93.9 Disorder of brain, unspecified	0.000	0.995	0.005
B18.9 Chronic viral hepatitis, unspecified	0.000	0.995	0.005
B25.0 Cytomegaloviral pneumonitis	0.005	0.995	0.000
G93.6 Cerebral oedema	0.000	0.995	0.005
B25.2 Cytomegaloviral pancreatitis	0.004	0.995	0.000
B25.1 Cytomegaloviral hepatitis	0.004	0.995	0.000
G93.0 Cerebral cysts	0.000	0.995	0.005
B15-B19 Viral hepatitis	0.000	0.995	0.004
B25.8 Other cytomegaloviral diseases	0.004	0.995	0.000
Z54.0 Convalescence following surgery	0.004	0.996	0.000
G93.7 Reye's syndrome	0.000	0.996	0.004
B17.1 Acute hepatitis C	0.000	0.996	0.004
G93.4 Encephalopathy, unspecified	0.000	0.996	0.004
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.996	0.004
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.996	0.004
G90-G99 Other disorders of the nervous system	0.000	0.996	0.004
B17 Other acute viral hepatitis	0.000	0.996	0.004
G91.2 Normal-pressure hydrocephalus	0.000	0.996	0.004
B16 Acute hepatitis B	0.000	0.996	0.004
G93.2 Benign intracranial hypertension	0.000	0.996	0.004
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.996	0.004
G91.0 Communicating hydrocephalus	0.000	0.996	0.004
G98 Other disorders of nervous system, not elsewhere classified	0.000	0.996	0.004
M89 Other disorders of bone	0.000	0.996	0.004
H40-H42 Glaucoma	0.000	0.996	0.004
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.996	0.004
K86.2 Cyst of pancreas	0.000	0.996	0.004
K86.1 Other chronic pancreatitis	0.000	0.996	0.004
K86.9 Disease of pancreas, unspecified	0.000	0.996	0.004
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.996	0.004
M89.9 Disorder of bone, unspecified	0.000	0.996	0.004
K86 Other diseases of pancreas	0.000	0.996	0.004
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
M89.96 Disorder of bone, unspecified (Lower leg)	0.000	0.996	0.004
G94 Other disorders of brain in diseases classified elsewhere	0.000	0.996	0.004
B08.1 Molluscum contagiosum	0.004	0.996	0.000
N82 Fistulae involving female genital tract	0.000	0.996	0.004
B15 Acute hepatitis A	0.000	0.996	0.003
G99 Other disorders of nervous system in diseases classified elsewhere	0.000	0.996	0.003
M89.91 Disorder of bone, unspecified (Shoulder region)	0.000	0.996	0.003
K29.4 Chronic atrophic gastritis	0.000	0.997	0.003
S42.40 Fracture of lower end of humerus (closed)	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
B17.8 Other specified acute viral hepatitis	0.000	0.997	0.003
G92 Toxic encephalopathy	0.000	0.997	0.003
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.000	0.997	0.003
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.000	0.997	0.003
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.000	0.997	0.003
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.000	0.997	0.003
M89.92 Disorder of bone, unspecified (Upper arm)	0.000	0.997	0.003
M21.3 Wrist or foot drop (acquired)	0.001	0.997	0.002
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.000	0.997	0.003
B17.9 Acute viral hepatitis, unspecified	0.000	0.997	0.003
B19 Unspecified viral hepatitis	0.001	0.997	0.002
N82.9 Female genital tract fistula, unspecified	0.000	0.997	0.003
B25-B34 Other viral diseases	0.003	0.997	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.997	0.003
M89.4 Other hypertrophic osteo-arthropathy	0.000	0.997	0.003
G96 Other disorders of central nervous system	0.000	0.997	0.003
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.003	0.997	0.000
G94.2 Hydrocephalus in other diseases classified elsewhere	0.000	0.997	0.003
Q39.6 Diverticulum of oesophagus	0.003	0.997	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.000	0.997	0.003
M89.6 Osteopathy after poliomyelitis	0.000	0.997	0.003
M89.3 Hypertrophy of bone	0.000	0.997	0.003
M89.2 Other disorders of bone development and growth	0.000	0.997	0.003
M89.1 Epiphyseal arrest	0.000	0.997	0.003
H42 Glaucoma in diseases classified elsewhere	0.000	0.997	0.003
K86.8 Other specified diseases of pancreas	0.000	0.997	0.003
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.997	0.003
N82.4 Other female intestinal-genital tract fistulae	0.000	0.997	0.003
N82.5 Female genital tract-skin fistulae	0.000	0.997	0.003
M89.99 Disorder of bone, unspecified (Site unspecified)	0.000	0.997	0.003
M89.93 Disorder of bone, unspecified (Forearm)	0.000	0.997	0.003
B17.2 Acute hepatitis E	0.000	0.997	0.003
D22.1 Melanocytic naevi of eyelid, including canthus	0.000	0.997	0.003
G94.1 Hydrocephalus in neoplastic disease	0.000	0.997	0.003
L30.8 Other specified dermatitis	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
M89.5 Osteolysis	0.000	0.997	0.003
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.000	0.997	0.003
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
B15.0 Hepatitis A with hepatic coma	0.000	0.997	0.003
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.000	0.997	0.003
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.000	0.997	0.003
N82.2 Fistula of vagina to small intestine	0.000	0.997	0.003
B15.9 Hepatitis A without hepatic coma	0.000	0.997	0.003
N82.8 Other female genital tract fistulae	0.000	0.997	0.003
I74.5 Embolism and thrombosis of iliac artery	0.003	0.997	0.000
K86.3 Pseudocyst of pancreas	0.000	0.997	0.003
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot	0.003	0.997	0.000
B34.8 Other viral infections of unspecified site	0.003	0.997	0.000
M89.98 Disorder of bone, unspecified (Other)	0.000	0.997	0.003
N82.1 Other female urinary-genital tract fistulae	0.000	0.997	0.003
B34 Viral infection of unspecified site	0.003	0.997	0.000
G97.8 Other postprocedural disorders of nervous system	0.000	0.997	0.003
K46 Unspecified abdominal hernia	0.000	0.997	0.003
G96.8 Other specified disorders of central nervous system	0.000	0.997	0.003
T79.3 Post-traumatic wound infection, not elsewhere classified	0.003	0.997	0.000
Q39 Congenital malformations of oesophagus	0.003	0.997	0.000
N82.0 Vesicovaginal fistula	0.000	0.997	0.003
Y40.0 Penicillins	0.003	0.997	0.000
M00.9 Pyogenic arthritis, unspecified	0.003	0.997	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.000	0.997	0.003
M21.39 Wrist or foot drop (acquired)-Site unspec	0.001	0.997	0.002
M21.38 Wrist or foot drop (acquired)-Other	0.001	0.997	0.002
M21.36 Wrist or foot drop (acquired)-Lower leg	0.001	0.997	0.002
M21.35 Wrist or foot drop (acquired)-Pelvic/thigh	0.001	0.997	0.002
M21.34 Wrist or foot drop (acquired) (Hand)	0.001	0.997	0.002
M21.32 Wrist or foot drop (acquired)-Upper arm	0.001	0.997	0.002
M21.31 Wrist or foot drop (acquired)-Shldr region	0.001	0.997	0.002
M21.30 Wrist or foot drop (acquired) (Multiple sites)	0.001	0.997	0.002
Y40.6 Rifamycins	0.002	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)	0.002	0.997	0.000
G97.9 Postprocedural disorder of nervous system, unspecified	0.000	0.997	0.002
G97.2 Intracranial hypotension following ventricular shunting	0.000	0.997	0.002
M96.0 Pseudarthrosis after fusion or arthrodesis	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
G93.3 Postviral fatigue syndrome	0.000	0.997	0.003
B19.0 Unspecified viral hepatitis with coma	0.001	0.997	0.002
B33 Other viral diseases, not elsewhere classified	0.002	0.997	0.000
M00.99 Pyogenic arthritis, unspecified (Site unspecified)	0.002	0.997	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.000	0.997	0.002
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.000	0.997	0.002
K11.8 Other diseases of salivary glands	0.003	0.997	0.000
Z04.9 Examination and observation for unspecified reason	0.003	0.997	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.000	0.998	0.002
M89.48 Other hypertrophic osteoarthropathy (Other)	0.000	0.998	0.002
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.000	0.998	0.002
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.000	0.998	0.002
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.000	0.998	0.002
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.000	0.998	0.002
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.000	0.998	0.002
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.000	0.998	0.002
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.000	0.998	0.002
L53.9 Erythematous condition, unspecified	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
B30 Viral conjunctivitis	0.002	0.998	0.000
B26 Mumps	0.002	0.998	0.000
M21.33 Wrist or foot drop (acquired) (Forearm)	0.001	0.998	0.002
D22.2 Melanocytic naevi of ear and external auricular canal	0.000	0.998	0.002
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Z98.2 Presence of cerebrospinal fluid drainage device	0.000	0.998	0.002
M89.19 Epiphyseal arrest (Site unspecified)	0.000	0.998	0.002
M89.18 Epiphyseal arrest (Other)	0.000	0.998	0.002
M89.17 Epiphyseal arrest (Ankle and foot)	0.000	0.998	0.002
M89.16 Epiphyseal arrest (Lower leg)	0.000	0.998	0.002
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.000	0.998	0.002
M89.14 Epiphyseal arrest (Hand)	0.000	0.998	0.002
M89.13 Epiphyseal arrest (Forearm)	0.000	0.998	0.002
M89.12 Epiphyseal arrest (Upper arm)	0.000	0.998	0.002
M89.11 Epiphyseal arrest (Shoulder region)	0.000	0.998	0.002
M89.10 Epiphyseal arrest (Multiple sites)	0.000	0.998	0.002
M89.29 Other disorders of bone development and growth (Site unspecified)	0.000	0.998	0.002
M89.28 Other disorders of bone development and growth (Other)	0.000	0.998	0.002
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.000	0.998	0.002
M89.26 Other disorders of bone development and growth (Lower leg)	0.000	0.998	0.002
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.000	0.998	0.002
M89.24 Other disorders of bone development and growth (Hand)	0.000	0.998	0.002
M89.23 Other disorders of bone development and growth (Forearm)	0.000	0.998	0.002
M89.22 Other disorders of bone development and growth (Upper arm)	0.000	0.998	0.002
M89.21 Other disorders of bone development and growth (Shoulder region)	0.000	0.998	0.002
M89.20 Other disorders of bone development and growth (Multiple sites)	0.000	0.998	0.002
M89.39 Hypertrophy of bone (Site unspecified)	0.000	0.998	0.002
M89.36 Hypertrophy of bone (Lower leg)	0.000	0.998	0.002
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.000	0.998	0.002
M89.34 Hypertrophy of bone (Hand)	0.000	0.998	0.002
M89.33 Hypertrophy of bone (Forearm)	0.000	0.998	0.002
M89.32 Hypertrophy of bone (Upper arm)	0.000	0.998	0.002
M89.31 Hypertrophy of bone (Shoulder region)	0.000	0.998	0.002
M89.30 Hypertrophy of bone (Multiple sites)	0.000	0.998	0.002
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.000	0.998	0.002
M89.68 Osteopathy after poliomyelitis (Other)	0.000	0.998	0.002
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.000	0.998	0.002
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.000	0.998	0.002
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.000	0.998	0.002
M89.64 Osteopathy after poliomyelitis (Hand)	0.000	0.998	0.002
M89.63 Osteopathy after poliomyelitis (Forearm)	0.000	0.998	0.002
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.000	0.998	0.002
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.000	0.998	0.002
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.000	0.998	0.002
Q39.4 Oesophageal web	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.998	0.002
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.998	0.002
B19.9 Unspecified viral hepatitis without coma	0.002	0.998	0.001
C09.9 Tonsil, unspecified	0.000	0.998	0.002
M21.86 Other specified acquired deformities of limbs (Lower leg)	0.002	0.998	0.000
C43.4 Malignant melanoma of scalp and neck	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
M00.94 Pyogenic arthritis, unspecified (Hand)	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
M89.59 Osteolysis (Site unspecified)	0.000	0.998	0.002
M89.58 Osteolysis (Other)	0.000	0.998	0.002
M89.57 Osteolysis (Ankle and foot)	0.000	0.998	0.002
M89.56 Osteolysis (Lower leg)	0.000	0.998	0.002
M89.54 Osteolysis (Hand)	0.000	0.998	0.002
M89.53 Osteolysis (Forearm)	0.000	0.998	0.002
M89.52 Osteolysis (Upper arm)	0.000	0.998	0.002
M89.51 Osteolysis (Shoulder region)	0.000	0.998	0.002
M89.50 Osteolysis (Multiple sites)	0.000	0.998	0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
M89.38 Hypertrophy of bone (Other)	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
B34.4 Papovirus infection, unspecified	0.002	0.998	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.000	0.998	0.002
Y40.4 Tetracyclines	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
D22 Melanocytic naevi	0.000	0.998	0.002
G96.9 Disorder of central nervous system, unspecified	0.000	0.998	0.002
M89.8 Other specified disorders of bone	0.000	0.998	0.002
Q39.9 Congenital malformation of oesophagus, unspecified	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
M21.4 Flat foot [pes planus] (acquired)	0.002	0.998	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.000	0.998	0.002
B34.3 Parvovirus infection, unspecified	0.002	0.998	0.000
B34.2 Coronavirus infection, unspecified	0.002	0.998	0.000
B34.0 Adenovirus infection, unspecified	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
G95.0 Syringomyelia and syringobulbia	0.000	0.998	0.002
K46.1 Unspecified abdominal hernia with gangrene	0.000	0.998	0.002
Y43 Primarily systemic agents	0.002	0.998	0.000
N25.8 Other disorders resulting from impaired renal tubular function	0.002	0.998	0.000
Q65.1 Congenital dislocation of hip, bilateral	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.000	0.998	0.002
Q39.8 Other congenital malformations of oesophagus	0.002	0.998	0.000
Q39.5 Congenital dilatation of oesophagus	0.002	0.998	0.000
Q39.3 Congenital stenosis and stricture of oesophagus	0.002	0.998	0.000
Q39.2 Congenital tracheooesophageal fistula without atresia	0.002	0.998	0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula	0.002	0.998	0.000
Q39.0 Atresia of oesophagus without fistula	0.002	0.998	0.000
G96.0 Cerebrospinal fluid leak	0.000	0.998	0.002
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.000	0.998	0.002
B33.2 Viral carditis	0.002	0.998	0.000
B34.1 Enterovirus infection, unspecified	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
B27 Infectious mononucleosis	0.002	0.998	0.000
M00.98 Pyogenic arthritis, unspecified (Other)	0.002	0.998	0.000
T79.6 Traumatic ischaemia of muscle	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
M21.8 Other specified acquired deformities of limbs	0.002	0.998	0.000
Q74.1 Congenital malformation of knee	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
S72.00 Fracture of neck of femur (closed)	0.000	0.998	0.002
H26.8 Other specified cataract	0.002	0.998	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.002	0.998	0.000
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)	0.002	0.998	0.000
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.002	0.998	0.000
B33.3 Retrovirus infections, not elsewhere classified	0.002	0.998	0.000
B33.1 Ross River disease	0.002	0.998	0.000
B33.0 Epidemic myalgia	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.000	0.998	0.002
B26.9 Mumps without complication	0.002	0.998	0.000
B26.8 Mumps with other complications	0.002	0.998	0.000
B26.3 Mumps pancreatitis	0.002	0.998	0.000
B26.2 Mumps encephalitis	0.002	0.998	0.000
B26.1 Mumps meningitis	0.002	0.998	0.000
B26.0 Mumps orchitis	0.002	0.998	0.000
B30.9 Viral conjunctivitis, unspecified	0.002	0.998	0.000
B30.8 Other viral conjunctivitis	0.002	0.998	0.000
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.002	0.998	0.000
B30.2 Viral pharyngoconjunctivitis	0.002	0.998	0.000
B30.1 Conjunctivitis due to adenovirus	0.002	0.998	0.000
B30.0 Keratoconjunctivitis due to adenovirus	0.002	0.998	0.000
F41.1 Generalised anxiety disorder	0.000	0.998	0.002
Q65 Congenital deformities of hip	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.002	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.000	0.998	0.002
R41.2 Retrograde amnesia	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
M00 Pyogenic arthritis	0.002	0.998	0.000
T79 Certain early complications of trauma, not elsewhere classified	0.002	0.998	0.000
Z54 Convalescence	0.002	0.998	0.000
M00.93 Pyogenic arthritis, unspecified (Forearm)	0.002	0.998	0.000
M00.92 Pyogenic arthritis, unspecified (Upper arm)	0.002	0.998	0.000
M84.04 Malunion of fracture (Hand)	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.002	0.998	0.000
M21.83 Other specified acquired deformities of limbs (Forearm)	0.002	0.998	0.000
B33.8 Other specified viral diseases	0.002	0.998	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.998	0.002
G97.0 Cerebrospinal fluid leak from spinal puncture	0.000	0.998	0.002
I34.1 Mitral (valve) prolapse	0.002	0.998	0.000
M00.0 Staphylococcal arthritis and polyarthritis	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
B91 Sequelae of poliomyelitis	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
T79.7 Traumatic subcutaneous emphysema	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.998	0.002
M89.81 Other specified disorders of bone (Shoulder region)	0.000	0.998	0.002
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot	0.002	0.998	0.000
M21.2 Flexion deformity	0.002	0.998	0.000
T78.8 Other adverse effects, not elsewhere classified	0.000	0.998	0.002
Y45.4 Antirheumatics	0.002	0.998	0.000
Q74 Other congenital malformations of limb(s)	0.002	0.998	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.998	0.002
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
K11.2 Sialoadenitis	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
R41 Other symptoms and signs involving cognitive functions and awareness	0.002	0.998	0.000
M00.01 Staphylococcal arthritis and polyarthritis (Shoulder region)	0.002	0.998	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.000	0.998	0.002
M89.80 Other specified disorders of bone (Multiple sites)	0.000	0.998	0.002
Q65.8 Other congenital deformities of hip	0.002	0.998	0.000
Q65.2 Congenital dislocation of hip, unspecified	0.002	0.998	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
M00.90 Pyogenic arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
M21.49 Flat foot [pes planus] (acquired)-Site unspec	0.002	0.998	0.000
M21.48 Flat foot [pes planus] (acquired)-Other	0.002	0.998	0.000
M21.46 Flat foot [pes planus] (acquired)-Lower leg	0.002	0.998	0.000
M21.45 Flat foot [pes planus] (acquired)-Pelvic/thigh	0.002	0.998	0.000
M21.44 Flat foot [pes planus] (acquired)-Hand	0.002	0.998	0.000
M21.43 Flat foot [pes planus] (acquired)-Forearm	0.002	0.998	0.000
M21.42 Flat foot [pes planus] (acquired)-Upper arm	0.002	0.998	0.000
M21.41 Flat foot [pes planus] (acquired)-Shldr region	0.002	0.998	0.000
M21.40 Flat foot [pes planus] (acquired)-Mult sites	0.002	0.998	0.000
Q38.5 Congenital malformations of palate, not elsewhere classified	0.002	0.998	0.000
G95 Other diseases of spinal cord	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
H26.0 Infantile, juvenile and presenile cataract	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
B94.8 Sequelae of other specified infectious and parasitic diseases	0.002	0.998	0.000
K10.2 Inflammatory conditions of jaws	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Q45 Other congenital malformations of digestive system	0.002	0.998	0.000
M00.06 Staphylococcal arthritis and polyarthritis (Lower leg)	0.002	0.998	0.000
M89.88 Other specified disorders of bone (Other)	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Z54.4 Convalescence following treatment of fracture	0.002	0.998	0.000
M21 Other acquired deformities of limbs	0.002	0.998	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.002	0.998	0.000
M25.53 Pain in joint (Forearm)	0.002	0.998	0.000
M54.16 Radiculopathy (Lumbar region)	0.000	0.998	0.002
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.000	0.998	0.002
B27.8 Other infectious mononucleosis	0.002	0.998	0.000
B27.1 Cytomegaloviral mononucleosis	0.002	0.998	0.000
B34.9 Viral infection, unspecified	0.002	0.998	0.000
M00.8 Arthritis and polyarthritis due to other specified bacterial agents	0.002	0.998	0.000
Q38.8 Other congenital malformations of pharynx	0.002	0.998	0.000
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
Q38.0 Congenital malformations of lips, not elsewhere classified	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
M00.91 Pyogenic arthritis, unspecified (Shoulder region)	0.002	0.998	0.000
M21.89 Other specified acquired deformities of limbs (Site unspecified)	0.002	0.998	0.000
M21.88 Other specified acquired deformities of limbs-Other	0.002	0.998	0.000
M21.85 Other specified acquired deformities of limbs (Pelvic region and thigh)	0.002	0.998	0.000
M21.84 Other specified acquired deformities of limbs (Hand)	0.002	0.998	0.000
M21.82 Other specified acquired deformities of limbs (Upper arm)	0.002	0.998	0.000
M21.81 Other specified acquired deformities of limbs (Shoulder region)	0.002	0.998	0.000
M21.80 Other specified acquired deformities of limbs (Multiple sites)	0.002	0.998	0.000
M21.9 Acquired deformity of limb, unspecified	0.002	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.000	0.998	0.002
M96.5 Postradiation scoliosis	0.002	0.998	0.000
Q45.3 Other congenital malformations of pancreas and pancreatic duct	0.002	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.000	0.998	0.001
Q38.4 Congenital malformations of salivary glands and ducts	0.002	0.998	0.000
Q38.3 Other congenital malformations of tongue	0.002	0.998	0.000
Q38.2 Macroglossia	0.002	0.998	0.000
Q38.1 Ankyloglossia	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Q65.9 Congenital deformity of hip, unspecified	0.002	0.998	0.000
Q65.6 Unstable hip	0.002	0.998	0.000
Q65.5 Congenital subluxation of hip, unspecified	0.002	0.998	0.000
Q65.4 Congenital subluxation of hip, bilateral	0.002	0.998	0.000
Q65.3 Congenital subluxation of hip, unilateral	0.002	0.998	0.000
Q65.0 Congenital dislocation of hip, unilateral	0.002	0.998	0.000
Q74.2 Other congenital malformations of lower limb(s), including pelvic girdle	0.002	0.998	0.000
T79.5 Traumatic anuria	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Z54.9 Convalescence following unspecified treatment	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
M54.19 Radiculopathy (Site unspecified)	0.000	0.998	0.002
D43.2 Brain, unspecified	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.000	0.998	0.002
M00.2 Other streptococcal arthritis and polyarthritis	0.002	0.998	0.000
M00.1 Pneumococcal arthritis and polyarthritis	0.002	0.998	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.002	0.998	0.000
Q74.0 Other congenital malformations of upper limb(s), including shoulder girdle	0.002	0.998	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.000	0.998	0.002
T79.9 Unspecified early complication of trauma	0.002	0.998	0.000
T79.4 Traumatic shock	0.002	0.998	0.000
T79.2 Traumatic secondary and recurrent haemorrhage	0.002	0.998	0.000
T79.1 Fat embolism (traumatic)	0.002	0.998	0.000
T79.0 Air embolism (traumatic)	0.002	0.998	0.000
Z54.7 Convalescence following combined treatment	0.002	0.998	0.000
Z54.3 Convalescence following psychotherapy	0.002	0.998	0.000
Z54.2 Convalescence following chemotherapy	0.002	0.998	0.000
Z54.1 Convalescence following radiotherapy	0.002	0.998	0.000
Q42 Congenital absence, atresia and stenosis of large intestine	0.002	0.998	0.000
Q41 Congenital absence, atresia and stenosis of small intestine	0.002	0.998	0.000
M00.09 Staphylococcal arthritis and polyarthritis (Site unspecified)	0.002	0.998	0.000
M00.08 Staphylococcal arthritis and polyarthritis (Other)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations